Maina Kava

545 total citations
22 papers, 267 citations indexed

About

Maina Kava is a scholar working on Molecular Biology, Clinical Biochemistry and Genetics. According to data from OpenAlex, Maina Kava has authored 22 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Clinical Biochemistry and 5 papers in Genetics. Recurrent topics in Maina Kava's work include Mitochondrial Function and Pathology (6 papers), Metabolism and Genetic Disorders (6 papers) and Genomics and Rare Diseases (4 papers). Maina Kava is often cited by papers focused on Mitochondrial Function and Pathology (6 papers), Metabolism and Genetic Disorders (6 papers) and Genomics and Rare Diseases (4 papers). Maina Kava collaborates with scholars based in Australia, Canada and United States. Maina Kava's co-authors include Mamta Muranjan, Milind S. Tullu, Katta M. Girisha, Shanti Balasubramaniam, Ravisha Srinivasjois, Shripada Rao, Anitha Thomas, Lisa G. Riley, John Christodoulou and Mark J. Cowley and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Clinical Nutrition and Human Mutation.

In The Last Decade

Maina Kava

19 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maina Kava Australia 10 112 64 60 48 42 22 267
Nidhi Shah United States 12 96 0.9× 136 2.1× 26 0.4× 59 1.2× 17 0.4× 40 339
Peter G. Procopis Australia 11 156 1.4× 90 1.4× 71 1.2× 47 1.0× 58 1.4× 28 426
Derya Erçal Türkiye 11 135 1.2× 123 1.9× 16 0.3× 117 2.4× 12 0.3× 41 341
Özlem Hergüner Türkiye 11 52 0.5× 42 0.7× 39 0.7× 149 3.1× 47 1.1× 44 377
Pin Fee Chong Japan 9 55 0.5× 47 0.7× 14 0.2× 26 0.5× 17 0.4× 33 202
Kitiwan Rojnueangnit Thailand 10 79 0.7× 95 1.5× 11 0.2× 33 0.7× 14 0.3× 28 232
Koumudi Godbole India 10 102 0.9× 36 0.6× 8 0.1× 82 1.7× 32 0.8× 22 295
Kirsten Baggesen Denmark 13 151 1.3× 67 1.0× 21 0.3× 23 0.5× 90 2.1× 25 476
Mitsuo Motobayashi Japan 10 62 0.6× 23 0.4× 16 0.3× 24 0.5× 72 1.7× 35 228
Nihaal Reddy India 10 37 0.3× 25 0.4× 25 0.4× 71 1.5× 25 0.6× 21 216

Countries citing papers authored by Maina Kava

Since Specialization
Citations

This map shows the geographic impact of Maina Kava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maina Kava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maina Kava more than expected).

Fields of papers citing papers by Maina Kava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maina Kava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maina Kava. The network helps show where Maina Kava may publish in the future.

Co-authorship network of co-authors of Maina Kava

This figure shows the co-authorship network connecting the top 25 collaborators of Maina Kava. A scholar is included among the top collaborators of Maina Kava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maina Kava. Maina Kava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woodcock, Ian, Didu Kariyawasam, Maina Kava, et al.. (2025). Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in Australian Hospitals. Neurology and Therapy. 14(3). 1007–1022.
2.
Morrison, David, et al.. (2025). A new tool for laryngeal electromyography in the Australian paediatric population. International Journal of Pediatric Otorhinolaryngology. 195. 112439–112439.
3.
Selvanathan, Arthavan, Won‐Tae Kim, Maina Kava, et al.. (2022). 3‐Methylglutaconyl‐CoA hydratase deficiency: When ascertainment bias confounds a biochemical diagnosis. JIMD Reports. 63(6). 568–574. 6 indexed citations
4.
Riley, Lisa G., Minal Menezes, Andrew Williams, et al.. (2021). FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in children. Molecular Genetics and Metabolism. 135(1). 63–71. 15 indexed citations
5.
Rius, Rocío, Alison G. Compton, Naomi L. Baker, et al.. (2021). Application of Genome Sequencing from Blood to Diagnose Mitochondrial Diseases. Genes. 12(4). 607–607. 7 indexed citations
6.
Riley, Lisa G., Mark J. Cowley, Velimir Gayevskiy, et al.. (2020). The diagnostic utility of genome sequencing in a pediatric cohort with suspected mitochondrial disease. Genetics in Medicine. 22(7). 1254–1261. 45 indexed citations
7.
Wintjes, Liesbeth T., Maina Kava, Mariël A.M. van den Brand, et al.. (2020). A novel variant in COX16 causes cytochrome c oxidase deficiency, severe fatal neonatal lactic acidosis, encephalopathy, cardiomyopathy, and liver dysfunction. Human Mutation. 42(2). 135–141. 4 indexed citations
9.
Jacoby, Peter, Donna Cross, Susan Morris, et al.. (2020). Benefits of powered standing wheelchair devices for adolescents with Duchenne muscular dystrophy in the first year of use. Journal of Paediatrics and Child Health. 56(9). 1419–1425. 12 indexed citations
10.
Evans, Kerry, Nada Murphy, Maina Kava, et al.. (2019). Powered standing wheelchairs promote independence, health and community involvement in adolescents with Duchenne muscular dystrophy. Neuromuscular Disorders. 29(3). 221–230. 22 indexed citations
11.
Rius, Rocío, Nicole J. Van Bergen, Alison G. Compton, et al.. (2019). Clinical Spectrum and Functional Consequences Associated with Bi-Allelic Pathogenic PNPT1 Variants. Journal of Clinical Medicine. 8(11). 2020–2020. 20 indexed citations
12.
Kava, Maina, et al.. (2018). Ketogenic diet, a potentially valuable therapeutic option for the management of refractory epilepsy in classical neonatal nonketotic hyperglycinemia: a case report. European Journal of Clinical Nutrition. 73(6). 961–965. 11 indexed citations
13.
Kava, Maina, et al.. (2018). Erythropoietic protoporphyria: A rare cause of painful hands and feet. Journal of Paediatrics and Child Health. 55(2). 236–238. 1 indexed citations
14.
Kava, Maina, Peter Walsh, Ravisha Srinivasjois, et al.. (2017). Clinical and Electrophysiological Characteristics of Vincristine Induced Peripheral Neuropathy in Children. SHILAP Revista de lepidopterología. 4 indexed citations
15.
Love, Jennifer M., et al.. (2016). Two Novel GLDC Mutations in a Neonate with Nonketotic Hyperglycinemia. Journal of Pediatric Genetics. 5(3). 174–180. 5 indexed citations
16.
Kava, Maina, David Chitayat, Susan Blasér, Peter N. Ray, & Jiri Vajsar. (2013). Eye and Brain Abnormalities in Congenital Muscular Dystrophies Caused by Fukutin-Related Protein Gene (FKRP) Mutations. Pediatric Neurology. 49(5). 374–378. 12 indexed citations
17.
Kava, Maina, et al.. (2012). C.P.5 Three siblings with multi-minicore myopathy not associated with SEPN1 or RYR1 mutations. Neuromuscular Disorders. 22(9-10). 842–842.
18.
Kava, Maina, Michael Bynevelt, Francis J. Lannigan, & Lakshmi Nagarajan. (2011). Horner’s Syndrome in a Child With Otitis Media: An Unusual Complication. Pediatric Neurology. 45(3). 209–210. 3 indexed citations
19.
Srinivasjois, Ravisha, Maina Kava, Anitha Thomas, & Shripada Rao. (2007). Cytomegalovirus‐associated ileal stricture in a preterm neonate. Journal of Paediatrics and Child Health. 44(1-2). 80–82. 19 indexed citations
20.
Kava, Maina, Milind S. Tullu, Mamta Muranjan, & Katta M. Girisha. (2004). Down syndrome:. Archives of Medical Research. 35(1). 31–35. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026